Literature DB >> 20216082

Hepatocellular carcinoma (HCC): a global perspective.

Peter Ferenci1, Michael Fried, Douglas Labrecque, Jordi Bruix, Morris Sherman, Masao Omata, Jenny Heathcote, Teehra Piratsivuth, Mike Kew, Jesse A Otegbayo, S S Zheng, S Sarin, Saeed S Hamid, Salma Barakat Modawi, Wolfgang Fleig, Suliman Fedail, Alan Thomson, Aamir Khan, Peter Malfertheiner, George Lau, Flair J Carillo, Justus Krabshuis, Anton Le Mair.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20216082     DOI： 10.1097/MCG.0b013e3181d46ef2

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  90 in total

1.  Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.

Authors:  M Sherman; K Burak; J Maroun; P Metrakos; J J Knox; R P Myers; M Guindi; G Porter; J R Kachura; P Rasuli; S Gill; P Ghali; P Chaudhury; J Siddiqui; D Valenti; A Weiss; R Wong
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

2.  Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Jia-Yan Ni; Shan-Shan Liu; Lin-Feng Xu; Hong-Liang Sun; Yao-Ting Chen
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

Review 3.  Surveillance of the Patients with High Risk of Hepatocellular Cancer.

Authors:  Necati Örmeci
Journal:  J Gastrointest Cancer       Date:  2017-09

4.  Elevated Serum Carcinoembryonic Antigen Is Associated with a Worse Survival Outcome of Patients After Liver Resection for Hepatocellular Carcinoma: a Propensity Score Matching Analysis.

Authors:  Jianwei Liu; Yong Xia; Lehua Shi; Xifeng Li; Lu Wu; Zhenlin Yan
Journal:  J Gastrointest Surg       Date:  2016-10-11       Impact factor: 3.452

Review 5.  Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma.

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

6.  Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone.

Authors:  Yongxiang Yi; Yufeng Zhang; Qiang Wei; Liang Zhao; Jianbo Han; Yan Song; Ying Ding; Guilan Lu; Junmao Liu; Huaiying Ding; Feng Dai; Xiaojun Tang
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 7.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

Review 8.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

Review 9.  Role of US LI-RADS in the LI-RADS Algorithm.

Authors:  Shuchi K Rodgers; David T Fetzer; Helena Gabriel; James H Seow; Hailey H Choi; Katherine E Maturen; Ashish P Wasnik; Tara A Morgan; Nirvikar Dahiya; Mary K O'Boyle; Yuko Kono; Claude B Sirlin; Aya Kamaya
Journal:  Radiographics       Date:  2019 May-Jun       Impact factor: 5.333

10.  Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.

Authors:  T T Zhang; X Q Zhao; Z Liu; Z Y Mao; L Bai
Journal:  Clin Transl Oncol       Date:  2015-11-17       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.